Abstract
Background
Follicular thyroid carcinoma (FTC) and follicular variant of papillary thyroid carcinoma (FV-PTC) are difficult entities to distinguish based on cytology prior to pathologic evaluation of surgical specimens but may have different treatment algorithms. The current study describes trends in rates of FTC versus FV-PTC in the U.S. and develops a risk assessment tool to aid clinicians in predicting final diagnosis and shaping treatment plans.
Methods
Relative rates of FTC and FV-PTC in the surveillance, epidemiology, and end results (SEER) database were evaluated for temporal trends from 1988 to 2011. Using multivariable logistic regression, a simplified scoring system was developed to estimate the risk of FTC versus FV-PTC using patient and tumor characteristics. The National Cancer Data Base was used for model validation.
Results and Discussion
Of 115,091 thyroid cancer cases in the SEER database from 1988 to 2011, 23,980 involved FTC (n = 5056; 21 %) or FV-PTC (n = 18,924; 79 %). In 1988, half of follicular cases were FV-PTC; however, FV-PTC accounted for over 85 % of these lesions by 2010. Increasing age >45 years, male gender, black race, increasing tumor size, and distant metastases were strongly associated with increased risk of FTC, while lymph node disease and extrathyroidal extension were associated with FV-PTC. A bedside risk assessment nomogram using these preoperative variables classified patient risk of FTC from 2 to 70 %. FV-PTC has become the dominant malignancy with follicular cytology, accounting for >85 % of these cases. A simple bedside risk assessment tool can risk stratify patients with follicular lesions and inform patient and clinician discussions and decision making.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Siegel R, Ma J, Zou Z et al (2014) Cancer statistics, 2014. CA Cancer J Clin 64:9–29
Pellegriti G, Frasca F, Regalbuto C et al (2013) Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol 2013:965212
DeSantis CE, Lin CC, Mariotto AB et al (2014) Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 64:252–271
Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295:2164–2167
Aschebrook-Kilfoy B, Grogan RH, Ward MH et al (2013) Follicular thyroid cancer incidence patterns in the United States, 1980-2009. Thyroid 23:1015–1021
Yu XM, Schneider DF, Leverson G et al (2013) Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases. Thyroid 23:1263–1268
Lin HW, Bhattacharyya N (2010) Clinical behavior of follicular variant of papillary thyroid carcinoma: presentation and survival. Laryngoscope 120:712–716
Lin HS, Komisar A, Opher E et al (2000) Follicular variant of papillary carcinoma: the diagnostic limitations of preoperative fine-needle aspiration and intraoperative frozen section evaluation. Laryngoscope 110:1431–1436
Kesmodel SB, Terhune KP, Canter RJ et al (2003) The diagnostic dilemma of follicular variant of papillary thyroid carcinoma. Surgery 134:1005–1012
Cibas ES, Ali SZ (2009) The bethesda system for reporting thyroid cytopathology. Am J Clin Pathol 132:658–665
Bongiovanni M, Spitale A, Faquin WC et al (2012) The bethesda system for reporting thyroid cytopathology: a meta-analysis. Acta Cytol 56:333–339
Howlader N, Noone AM, Krapcho M et al (2014) SEER cancer statistics review, 1975-2011. National Cancer Institute, Bethesda
American College of Surgeons. National Cancer Data Base 2013 [3/10/2014]. http://www.facs.org/cancer/ncdb/
Committee on Cancer. FORDS: Facility Oncology Registry Data Standards, Revised for 2013: Commission on Cancer; 2013 [6/29/2014]. http://www.facs.org/cancer/coc/fords/fords-manual-2013.pdf
Adamo MB, Johnson CH, Ruhl JL et al (2013) 2013 SEER program coding and staging manual. National Cancer Institute, Bethesda
Iasonos A, Schrag D, Raj GV et al (2008) How to build and interpret a nomogram for cancer prognosis. J Clin Oncol 26:1364–1370
Albores-Saavedra J, Henson DE, Glazer E et al (2007) Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype–papillary, follicular, and anaplastic: a morphological and epidemiological study. Endocr Pathol 18:1–7
Baloch ZW, Livolsi VA (2002) Follicular-patterned lesions of the thyroid: the bane of the pathologist. Am J Clin Pathol 117:143–150
LiVolsi VA, Baloch ZW (2005) Use and abuse of frozen section in the diagnosis of follicular thyroid lesions. Endocr Pathol 16:285–293
Shen PU, Kuhel WI, Yang GC et al (1997) Intraoperative touch-imprint cytological diagnosis of follicular variant of papillary thyroid carcinoma. Diagn Cytopathol 17:80–83
Cooper DS, Doherty GM, Haugen BR et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214
Alexander EK, Kennedy GC, Baloch ZW et al (2012) Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med 367:705–715
Chudova D, Wilde JI, Wang ET et al (2010) Molecular classification of thyroid nodules using high-dimensionality genomic data. J Clin Endocrinol Metab 95:5296–5304
McFadden DG, Dias-Santagata D, Sadow PM et al (2014) Identification of oncogenic mutations and gene fusions in the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab 99:E2457–E2462
Nikiforov YE, Carty SE, Chiosea SI et al (2014) Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay. Cancer 120:3627–3634
Nikiforov YE, Ohori NP, Hodak SP et al (2011) Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab 96:3390–3397
Armstrong MJ, Yang H, Yip L et al (2014) PAX8/PPARgamma rearrangement in thyroid nodules predicts follicular-pattern carcinomas, in particular the encapsulated follicular variant of papillary carcinoma. Thyroid 24:1369–1374
Cancer Genome Atlas Research N (2014) Integrated genomic characterization of papillary thyroid carcinoma. Cell 159:676–690
Lee L, How J, Tabah RJ et al (2014) Cost-effectiveness of molecular testing for thyroid nodules with atypia of undetermined significance cytology. J Clin Endocrinol Metab 99:2674–2682
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
The data used in the study are derived from a de-identified NCDB file. The American College of Surgeons and the Commission on Cancer have not verified and are not responsible for the analytic or statistical methodology employed, or the conclusions drawn from these data by the investigator.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Englum, B.R., Pura, J., Reed, S.D. et al. A Bedside Risk Calculator to Preoperatively Distinguish Follicular Thyroid Carcinoma from Follicular Variant of Papillary Thyroid Carcinoma. World J Surg 39, 2928–2934 (2015). https://doi.org/10.1007/s00268-015-3192-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-015-3192-4